SIETES :: 92469 citas

Resultados de la búsqueda por REVISIÓN REFINAR BÚSQUEDA

1.

Navarese EP, Robinson JG, Kowatewski M, Kotodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering. A systematic review and meta-analysis. JAMA 2018;319:17 de abril. [Ref.ID 102784]

2.

Navar AM, Peterson ED. Challenges in interpreting the lipid-lowering trials: biology vs ecology. JAMA 2018;319:17 de abril. [Ref.ID 102783]

3.

Wallach JD, Ross JS. Gabapentin approvals, off-label use, and lessons for postmarketing evaluation efforts. JAMA 2018;319:27 de febrero. [Ref.ID 102781]

4.

Moore A, Derry S, Wiffen P. Gabapentin for chronic neuropathic pain. JAMA 2018;319:27 de febrero. [Ref.ID 102777]

5.

Coustan DR, Barbour L. Insulin vs glyburide for gestational diabetes. JAMA 2018;319:1 de junio. [Ref.ID 102765]

6.

Ramaekers JG. Driving under the influence of cannabis. An increasing public health concern. JAMA 2018;319:10 de abril. [Ref.ID 102668]

7.

Anónimo. Conjonctivites présumées bactériennes. Prescrire 2018;38:361-5. [Ref.ID 102660]

8.

Anónimo. Alectinib et cancers bronchiques ALK-positifs. Prescrire 2018;38:337-9. [Ref.ID 102653]

9.

Anónimo. Acide obéticholique et cholangite biliaire primitive. Prescrire 2018;38:326-7. [Ref.ID 102652]

10.

Yong HY, McKay KA, Daley CGJ, Tremlett H. Drug exposure and the risk of multiple sclerosis: a systematic review. Pharmacoepidemiol Drug Saf 2018;27:febrero. [Ref.ID 102630]

11.

Anónimo. Nétupitant + palonosétron et prévention des vomissements chimio-induits. Prescrire 2018;38:176-7. [Ref.ID 102587]

12.

Anónimo. Baricitinib et polyarthrite rhumatoïde. Prescrire 2018;38:171-2. [Ref.ID 102586]

13.

Anónimo. Vaccin papillomavirus à 9 valences et cancer du col de l'utérus. Prescrire 2018;38:167-70. [Ref.ID 102585]

14.

Anónimo. Blinatumomab et leucémie aiguë lymphoblastique chez les adultes. Prescrire 2018;38:97-9. [Ref.ID 102582]

15.

Anónimo. Ixazomib et myélome multiple en echec. Prescrire 2018;38:95-7. [Ref.ID 102581]

16.

Anónimo. Éluxadoline et troubles fonctionnels intestinaux récurrents. Prescrire 2018;38:91-5. [Ref.ID 102580]

17.

Elia J. Celecoxib gets partial exoneration from FDA panels. Physician's First Watch 2018:26 de abril. [Ref.ID 102574]

18.

Law SWY, Wong AYS, Anand S, Wong ICK, Chan EW. Neurospychiatric events associated with leukotriene-modifying agents: a systematic review. Drug Saf 2018;41:marzo. [Ref.ID 102559]

19.

Stockings E, Zagic D, Campbell G, Weier M, Hall WD, Nielsen S, Herkes GK, Farrell M, Degenhardt L. Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. J Neurol Neurosurg Psychiatry 2018;89:741-53. [Ref.ID 102555]

20.

Dekkers T, Lafeber M, Kramers C. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2018;378:1 de febrero. [Ref.ID 102523]